Uses of Cordyceps sinensis MBF1 in the preparation of anti-radiation damage health products or drugs

TW202629231APending Publication Date: 2026-07-16HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD
Filing Date
2025-11-18
Publication Date
2026-07-16

Smart Images

  • Figure TWG2TA001069050_001
    Figure TWG2TA001069050_001
  • Figure TWG2TA001069050_002
    Figure TWG2TA001069050_002
  • Figure TWG2TA001069050_003
    Figure TWG2TA001069050_003
Patent Text Reader

Abstract

This invention discloses the application of Cordyceps sinensis MBF1 in the preparation of health products or drugs for the prevention and / or treatment of radiation damage, particularly its application in the preparation of health products or drugs for the prevention and / or treatment of intestinal radiation damage or hematopoietic system radiation damage caused by ionizing radiation. Cordyceps sinensis MBF1 can significantly improve symptoms caused by intestinal radiation damage, such as shortened colon length, small intestinal tissue damage, and elevated small intestinal inflammation levels, and improve symptoms caused by hematopoietic system radiation damage, such as decreased white blood cell count, decreased spleen index, and / or decreased thymus index. It can serve as a health product or drug for the prevention and treatment of radiation damage, especially intestinal radiation damage or hematopoietic system radiation damage, addressing the current lack of truly effective health products or drugs for the clinical treatment of intestinal radiation damage or hematopoietic system radiation damage. Simultaneously, it provides new ideas and strategies for the development of anti-radiation damage health products or drugs, possessing significant scientific and clinical application value.
Need to check novelty before this filing date? Find Prior Art